---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294724853.md"
description: "Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company."
datetime: "2026-08-03T17:55:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294724853.md)
  - [en](https://longbridge.com/en/news/294724853.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294724853.md)
generator: "portal-rs"
---

# 

Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.

### Related Stocks

- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)
- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)

## Related News & Research

- [Supernus Pharmaceuticals management attends Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297827223.md)
- [Supernus, Indivior agree all-stock merger, combined firm to trade as Supernus on Nasdaq](https://longbridge.com/en/news/294678697.md)
- [CalciMedica implements 1-for-5 reverse stock split to address Nasdaq $1 minimum bid rule](https://longbridge.com/en/news/297786457.md)
- [SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders](https://longbridge.com/en/news/297401736.md)
- [Trulieve highlights 2025 revenue of $1.2 billion in investor presentation](https://longbridge.com/en/news/297783638.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**